ClinVar Miner

Submissions for variant NM_001148.6(ANK2):c.7105G>T (p.Val2369Phe)

gnomAD frequency: 0.00004  dbSNP: rs758054052
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000230793 SCV000286256 uncertain significance Long QT syndrome 2023-03-07 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 238587). This variant has not been reported in the literature in individuals affected with ANK2-related conditions. This variant is present in population databases (rs758054052, gnomAD 0.01%). This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 2369 of the ANK2 protein (p.Val2369Phe).
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute RCV000853461 SCV000996372 uncertain significance Primary dilated cardiomyopathy 2017-06-20 criteria provided, single submitter research The ANK2 Val2369 variant has been reported previously in 1 Long QT (Invitae, ClinVar: SCV000286256.1) and 1 HCM patient (Lopes, et al., 2015). We identified this variant in a DCM proband that was diagnosed after suffering a cardiac arrest. The probands sibling passed away from cardiomyopathy and another family died suddenly however segregation was not possible. The variant is present in the Exome Aggregation Consortium dataset ( at an allele frequency > 0.00004, which is greater then expected for the disease. In silico models, SIFT, MutationTaster and PolyPhen-2 predict the change to be benign. In summary, the variant is present in the general population at a frequency higher then expected for the disease and in silico tools predict this variant to be benign, therefore we classify ANK2 Val2369Phe as a variant of 'uncertain significance'.
GeneDx RCV001785525 SCV002028069 uncertain significance not provided 2021-11-12 criteria provided, single submitter clinical testing Identified in patients with HCM in the published literature (Lopes et al., 2015); In silico analysis supports that this missense variant does not alter protein structure/function; Located in exon 38, which is reported as being expressed in a brain-specific transcript (Otto et al, 1991; Cunha et al, 2008; Wu et al, 2015); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 238587; Landrum et al., 2016); This variant is associated with the following publications: (PMID: 25351510)
Ambry Genetics RCV002365186 SCV002662628 likely benign Cardiovascular phenotype 2024-02-27 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Fulgent Genetics, Fulgent Genetics RCV002478848 SCV002792935 uncertain significance Cardiac arrhythmia, ankyrin-B-related 2022-01-08 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.